|
|
||||||||
CUTTING EDGE |




* Department of Medicine II, Hokkaido University Graduate School of Medicine, Sapporo, Japan; and
Division of Rheumatology and Immunology, Department of Internal Medicine, University of Virginia, Charlottesville, VA 22908
The cytotoxic function of CD178 (Fas ligand (FasL)) is critical to the maintenance of peripheral tolerance and immune-mediated tissue pathology. The active site of FasL resides at the FasL extracellular region (FasLExt) and it functions through binding/cross-linking Fas receptor on target cells. In this study, we report that FasLExt-mediated cytotoxicity is regulated by the FasL cytoplasmic tail (FasLCyt). Deleting the N-terminal 270 aa (
70) or N-terminal 233 aa (
33) reduced the cytotoxic strength as much as 30- to 100-fold. By contrast, change in the cytotoxic strength was not observed with FasL deleted of the proline-rich domains (4574 aa,
PRD) in the FasLCyt. Our study identifies a novel function of FasLCyt and demonstrates that FasL233, a sequence unique to FasL, is critically required for the optimal expression of FasLExt-mediated cytotoxicity.
This article has been cited by other articles:
![]() |
L. Zheng, R. Sharma, F. Gaskin, S. M. Fu, and S.-T. Ju A Novel Role of IL-2 in Organ-Specific Autoimmune Inflammation beyond Regulatory T Cell Checkpoint: Both IL-2 Knockout and Fas Mutation Prolong Lifespan of Scurfy Mice but by Different Mechanisms J. Immunol., December 15, 2007; 179(12): 8035 - 8041. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sun, S. Lee, S. Karray, M. Levi-Strauss, K. T. Ames, and P. J. Fink Cutting Edge: Two Distinct Motifs within the Fas Ligand Tail Regulate Fas Ligand-Mediated Costimulation J. Immunol., November 1, 2007; 179(9): 5639 - 5643. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sun, K. T. Ames, I. Suzuki, and P. J. Fink The Cytoplasmic Domain of Fas Ligand Costimulates TCR Signals J. Immunol., August 1, 2006; 177(3): 1481 - 1491. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |